AdaptVac 
Welcome,         Profile    Billing    Logout  
  Products    Diseases    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ABNCoV2 / University of Copenhagen, Leiden University Medical Center, Bavarian Nordic, AdaptVac, ExpreS2ion, University of Tuebingen
NCT05077267: ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects

Recruiting
2
210
Europe
ABNCoV2
Bavarian Nordic
COVID-19 Disease
12/21
02/24
COUGH-1, NCT04839146: Safety and Tolerability of COVID-19 Vaccine (ABNCoV2)

Active, not recruiting
1
45
Europe
ABNCoV2 Vaccine, cVLP-RBD, RBDn-CLP, ABNCoV2
Radboud University, European Union
Covid19, Severe Acute Respiratory Syndrome, SARS-CoV-2 Infection
12/21
12/21
ES2B-C001 / ExpreS2ion
No trials found

Download Options